ExoVasc® PEARS

Royal Brompton Hospital approves device

Share:

Following the completion of the initial clinical trial the Clinical Practice Committee at the Royal Brompton Hospital has approved the device for use in the treatment of suitable patients with a dilated aorta due to Marfan syndrome

Share:

Related articles

The 11 Beaches Walk raises money for research into cardiovascular disease

Dr Ana Redondo awarded the EACTS Presidents Choice Award at EACTS 2025

Interested in our patient experiences?